Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13955681 [patent_doc_number] => 20190054184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-21 [patent_title] => Targeting Macrophages to Modulate Electrical Conduction in the Heart [patent_app_type] => utility [patent_app_number] => 16/075931 [patent_app_country] => US [patent_app_date] => 2017-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14549 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16075931 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/075931
Targeting Macrophages to Modulate Electrical Conduction in the Heart Feb 12, 2017 Abandoned
Array ( [id] => 11836321 [patent_doc_number] => 20170218040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-03 [patent_title] => 'PROTEOLICALLY RESISTANT CYCLOTIDES WITH ANGIOTENSIN 1-7 LIKE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 15/422376 [patent_app_country] => US [patent_app_date] => 2017-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19892 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15422376 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/422376
PROTEOLICALLY RESISTANT CYCLOTIDES WITH ANGIOTENSIN 1-7 LIKE ACTIVITY Jan 31, 2017 Abandoned
Array ( [id] => 16738781 [patent_doc_number] => 10964443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-30 [patent_title] => Conductive yarn [patent_app_type] => utility [patent_app_number] => 16/073790 [patent_app_country] => US [patent_app_date] => 2017-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 27 [patent_no_of_words] => 22531 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073790 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/073790
Conductive yarn Jan 28, 2017 Issued
Array ( [id] => 16704393 [patent_doc_number] => 10954313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-23 [patent_title] => Composition comprising SP1 and carbon based nanoparticles and uses thereof [patent_app_type] => utility [patent_app_number] => 16/073789 [patent_app_country] => US [patent_app_date] => 2017-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 43 [patent_no_of_words] => 38494 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073789 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/073789
Composition comprising SP1 and carbon based nanoparticles and uses thereof Jan 28, 2017 Issued
Array ( [id] => 11888004 [patent_doc_number] => 09758556 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-09-12 [patent_title] => 'Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5' [patent_app_type] => utility [patent_app_number] => 15/418311 [patent_app_country] => US [patent_app_date] => 2017-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 56 [patent_no_of_words] => 18156 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15418311 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/418311
Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5 Jan 26, 2017 Issued
Array ( [id] => 11888003 [patent_doc_number] => 09758555 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-09-12 [patent_title] => 'Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5' [patent_app_type] => utility [patent_app_number] => 15/418247 [patent_app_country] => US [patent_app_date] => 2017-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 56 [patent_no_of_words] => 18158 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15418247 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/418247
Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5 Jan 26, 2017 Issued
Array ( [id] => 15510281 [patent_doc_number] => 10561707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-18 [patent_title] => Semaphorin 3C variants, compositions comprising said variants and methods of use thereof in treating eye diseases [patent_app_type] => utility [patent_app_number] => 15/413991 [patent_app_country] => US [patent_app_date] => 2017-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 96 [patent_no_of_words] => 29330 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15413991 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/413991
Semaphorin 3C variants, compositions comprising said variants and methods of use thereof in treating eye diseases Jan 23, 2017 Issued
Array ( [id] => 12030812 [patent_doc_number] => 20170320911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-09 [patent_title] => 'HIGH AFFINITY METAL-OXIDE BINDING PEPTIDES WITH REVERSIBLE BINDING' [patent_app_type] => utility [patent_app_number] => 15/413291 [patent_app_country] => US [patent_app_date] => 2017-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15331 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15413291 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/413291
HIGH AFFINITY METAL-OXIDE BINDING PEPTIDES WITH REVERSIBLE BINDING Jan 22, 2017 Abandoned
Array ( [id] => 13840565 [patent_doc_number] => 20190023767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-24 [patent_title] => NOVEL POLYPEPTIDES AND MEDICAL USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/066912 [patent_app_country] => US [patent_app_date] => 2017-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16066912 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/066912
Polypeptides and medical uses thereof Jan 19, 2017 Issued
Array ( [id] => 13297573 [patent_doc_number] => 20180200323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => USE OF TETRAPEPTIDE -3 GEKG OR PENTAPEPTIDE -3 GEKGF FOR TREATING DEGENERATIVE JOINT DISEASE [patent_app_type] => utility [patent_app_number] => 15/406912 [patent_app_country] => US [patent_app_date] => 2017-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2073 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15406912 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/406912
USE OF TETRAPEPTIDE -3 GEKG OR PENTAPEPTIDE -3 GEKGF FOR TREATING DEGENERATIVE JOINT DISEASE Jan 15, 2017 Abandoned
Array ( [id] => 13790793 [patent_doc_number] => 20190008935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-10 [patent_title] => METHODS AND USES FOR ALPHA-1 ANTITRYPSIN OR RECOMBINANT FORMS THEREOF, ON STEROID-REFRACTORY GRAFT VERSUS HOST DISEASE INVOLVING GASTROINTESTINAL COMPLICATIONS [patent_app_type] => utility [patent_app_number] => 16/067076 [patent_app_country] => US [patent_app_date] => 2016-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12636 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16067076 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/067076
METHODS AND USES FOR ALPHA-1 ANTITRYPSIN OR RECOMBINANT FORMS THEREOF, ON STEROID-REFRACTORY GRAFT VERSUS HOST DISEASE INVOLVING GASTROINTESTINAL COMPLICATIONS Dec 29, 2016 Abandoned
Array ( [id] => 16430683 [patent_doc_number] => 10830762 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-10 [patent_title] => Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases [patent_app_type] => utility [patent_app_number] => 16/066288 [patent_app_country] => US [patent_app_date] => 2016-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 49 [patent_no_of_words] => 458790 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 257 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16066288 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/066288
Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases Dec 26, 2016 Issued
Array ( [id] => 13777983 [patent_doc_number] => 20190002530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN PARTICLE-CONTAINING CELL, AND METHOD FOR PRODUCING GELATIN PARTICLE-CONTAINING CELL [patent_app_type] => utility [patent_app_number] => 16/064828 [patent_app_country] => US [patent_app_date] => 2016-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6638 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16064828 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/064828
GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN PARTICLE-CONTAINING CELL, AND METHOD FOR PRODUCING GELATIN PARTICLE-CONTAINING CELL Dec 18, 2016 Abandoned
Array ( [id] => 11820583 [patent_doc_number] => 20170209521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-27 [patent_title] => 'SMALL MOLECULE CANCER TREATMENTS THAT CAUSE NECROSIS IN CANCER CELLS BUT DO NOT AFFECT NORMAL CELLS' [patent_app_type] => utility [patent_app_number] => 15/372229 [patent_app_country] => US [patent_app_date] => 2016-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15387 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15372229 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/372229
SMALL MOLECULE CANCER TREATMENTS THAT CAUSE NECROSIS IN CANCER CELLS BUT DO NOT AFFECT NORMAL CELLS Dec 6, 2016 Abandoned
Array ( [id] => 13899021 [patent_doc_number] => 20190038715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-07 [patent_title] => PEPTIDES DERIVED FROM ACTIN-LIKE PROTEIN 8 (ACTL8) [patent_app_type] => utility [patent_app_number] => 15/777144 [patent_app_country] => US [patent_app_date] => 2016-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777144 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/777144
Peptides derived from actin-like protein 8 (ACTL8) Nov 22, 2016 Issued
Array ( [id] => 16695536 [patent_doc_number] => 10946105 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Peptides derived from transient receptor potential cation channel subfamily M member 1 (TRPM1), complexes comprising such peptides bound to MHC molecules [patent_app_type] => utility [patent_app_number] => 15/778206 [patent_app_country] => US [patent_app_date] => 2016-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 18 [patent_no_of_words] => 9783 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778206 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/778206
Peptides derived from transient receptor potential cation channel subfamily M member 1 (TRPM1), complexes comprising such peptides bound to MHC molecules Nov 22, 2016 Issued
Array ( [id] => 16695536 [patent_doc_number] => 10946105 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Peptides derived from transient receptor potential cation channel subfamily M member 1 (TRPM1), complexes comprising such peptides bound to MHC molecules [patent_app_type] => utility [patent_app_number] => 15/778206 [patent_app_country] => US [patent_app_date] => 2016-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 18 [patent_no_of_words] => 9783 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778206 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/778206
Peptides derived from transient receptor potential cation channel subfamily M member 1 (TRPM1), complexes comprising such peptides bound to MHC molecules Nov 22, 2016 Issued
Array ( [id] => 16695536 [patent_doc_number] => 10946105 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Peptides derived from transient receptor potential cation channel subfamily M member 1 (TRPM1), complexes comprising such peptides bound to MHC molecules [patent_app_type] => utility [patent_app_number] => 15/778206 [patent_app_country] => US [patent_app_date] => 2016-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 18 [patent_no_of_words] => 9783 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778206 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/778206
Peptides derived from transient receptor potential cation channel subfamily M member 1 (TRPM1), complexes comprising such peptides bound to MHC molecules Nov 22, 2016 Issued
Array ( [id] => 16695536 [patent_doc_number] => 10946105 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Peptides derived from transient receptor potential cation channel subfamily M member 1 (TRPM1), complexes comprising such peptides bound to MHC molecules [patent_app_type] => utility [patent_app_number] => 15/778206 [patent_app_country] => US [patent_app_date] => 2016-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 18 [patent_no_of_words] => 9783 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778206 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/778206
Peptides derived from transient receptor potential cation channel subfamily M member 1 (TRPM1), complexes comprising such peptides bound to MHC molecules Nov 22, 2016 Issued
Array ( [id] => 16649992 [patent_doc_number] => 10927155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-23 [patent_title] => Dual inhibitory action peptidomimetic inhibitor for IL-33 and IL-1beta [patent_app_type] => utility [patent_app_number] => 15/776932 [patent_app_country] => US [patent_app_date] => 2016-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 29 [patent_no_of_words] => 26380 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15776932 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/776932
Dual inhibitory action peptidomimetic inhibitor for IL-33 and IL-1beta Nov 17, 2016 Issued
Menu